Understanding the latest innovative technologies.

Study investigators found that the injuries ranged from deep thermal burns to full-thickness corneal or scleral lacerations, with one case of traumatic cataract.

Specular microscopy showed that the ocular symptoms in the patients who had had COVID-19 included conjunctival hyperemia, foreign body sensation, tearing, ocular secretion, and chemosis.

The alert follows a warning letter issued by US FDA to a company that manufacturers eye drops that claim to change eye color.

The programs make vision care more affordable and accessible for underserved communities.

UPTE states that although UC's proposal has improved from previous proposals, it still "leaves a lot to be desired."

Actionable tips to improve comfort and fit.

A research team for the $3.3 million study will assess the front and the back of the eye and different types of glucose dysfunction.

Some cases require unorthodox approaches.

Exploring myopia control treatment efficacy does not demand clinical complexity.

Catch up on what happened in optometry during the week of August 12-August 16.

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, weigh in on meibomian gland dysfunction and dry eye disease what to consider when choosing symptom management options.

The survey’s results were released by Bausch + Lomb last month and revealed that many participants did not know their symptoms were dry eye-related.

Both seasoned and newer practice owners share their insights for preventing burnout through practice management.

Estimating the number of such visits in the US may help guide research and clinical efforts to optimize outcomes, according to the researchers.

The study found that of Medicaid enrollees, 12% do not have coverage for routine adult eye exams and 27% are without coverage for eyeglasses.

Jack Chapman, MD, weighs in on the importance of nailing refraction on the first visit to the optometrist's office in the light adjustable lens fitting process after identifying the best candidate.

It’s time to act with a few rational and relatively modest proposals.

LNZ100 is an aceclidine-based ophthalmic solution and demonstrated statistically significant results in the Phase 3 CLARITY study.

Catch up on what happened in optometry during the week of August 5-August 9.